Hepatitis C Virus World Community Advisory Board

Activists from 22 countries joined forces at the first-ever HCV World CAB to demand equitable access to HCV treatment from six multinational pharmaceutical companies. More

“There is no question that these treatments that can save millions of lives must be made universally available at an affordable price.” More

Treatment activists held the first global LMIC-focused dialogue with pharmaceutical companies that produce HCV treatment, co-organized by TAG and the Asia Pacific Network of PLHA. More